Nanoscope Therapeutics appoints Glenn Sblendorio to its Board of Directors as Chairman
– USA, TX – Nanoscope Therapeutics, a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced the appointment of Glenn Sblendorio as Chairman of the Board of Directors, effective immediately.…